17.90 USD
↗ 0.27 (1.53%)AT CLOSE (AS OF 07:31 PM EDT)
NovoCure Limited Ordinary Shares
NVCRNASDAQ • USD
Market: CLOSED
NVCR is currently priced at $17.90. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place NVCR at a fair price relative to peers.
Technical & fundamental data as of Aug 26, 2026.
Open?$17.43
High?$17.97
Low?$17.15
Prev. Close?$17.62
Volume?1.3M
Avg. Volume?1.7M
VWAP?$17.64
Rel. Volume?0.77x
Bid / Ask
Bid?$16.06 × 100
Ask?$18.00 × 100
Spread?$1.94
Midpoint?$17.03
Valuation & Ratios
Market Cap?2.1B
Shares Out?116.4M
Float?104.8M
Float %?90.5%
P/E Ratio?N/A
P/B Ratio?6.16
EPS?-$1.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
Themes
Employees
1.6K
Market Cap
2.1B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2015-10-02
Address
NO. 4 THE FORUM
ST. HELIER,
Phone: 44 (0)15 3475 6700
ST. HELIER,
Phone: 44 (0)15 3475 6700
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?13
Momentum?80
Short Sent.?39
Piotroski F-Score?4/9Mixed
Altman Z-Score?1.14Distress
Confidence?60%Moderate
Short InterestHigh
Short % of Float?8.75%Elevated
Short Interest?9.2M
Days to Cover?8.4
Free Float104.8M
Avg Daily Volume1.1M
Settlement Date2026-08-14
Financial Health
Current Ratio?2.89Strong
Quick Ratio?2.70Strong
Cash Ratio?0.42Low
Debt/Equity?0.58Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?6.16FAIR▾
Peers100
S&P30
P/S?2.98CHEAP▾
Peers100
S&P51
P/FCF?N/A▾
EV/EBITDA?-15.8CHEAP▾
S&P97
EV/Sales?3.13FAIR▾
Peers100
S&P59
Returns & Efficiency
ROE?-43.9%WEAK▾
S&P3
ROA?-18.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-25434000
Enterprise Value?$2.2B
Fundamentals ratios updated end of day